A clinicalm trial to study the effects of a herbal drug Dawa-e-Musakkin in patients with anxity and Tension

A Clinical Study of Dawa-e- Musakkin in the treatment of Generalized Anxiety Disorder (GAD).

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2009/091/000761

Enrollment

Registered

2009-10-07

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Dawa-e-Musakkin: 2 gram OD for 3 months Control Intervention1: placebo: 2 gram OD for 3 months

Eligibility

Inclusion criteria

Inclusion criteria: ?Age and Sex- 18-60 years, either sex ?Patients diagnosed as cases of generalized anxiety disorder according to DSM-IV diagnostic Criteria

Exclusion criteria

Exclusion criteria: ?Pregnancy or lactation ?Women patients above 45 years of age( Post menopausal women) ?Patients with past or current history of cigarette smoking, drug or alcohol abuse. ?Patients of hyperthyroidism or hypothyroidism. ?Patients with a history of hypoglycemic episodes. ?Any cardiovascular /or chest diseases

Design outcomes

Primary

Measure	Time frame
Reduction in mean Hamilton Anxiety Rating scoreTimepoint: 4,8,12 week	—

Secondary

Measure	Time frame
Improvement in performanceTimepoint: 3 months	—

Countries

India

Contacts

Public ContactYasmeen Shamsi

yasmeen.ijum@gmail.com01126059692, Ext. 5930, 5723

Outcome results